Mild premorbid intellectual impairment as a resilience factor in Down syndrome associated Alzheimer's disease

Cognitive decline timing and slope differ depending on PII level, but AD biomarker pathology does not. If cognition is used for staging or endpoints in clinical trials, then PII should be considered.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70856_099392
Primary Topic
Down syndrome and intellectual disability research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Mild premorbid intellectual impairment as a resilience factor in Down syndrome associated Alzheimer's disease

James Tyler Kennedy
Alzheimer s & Dementia
Down syndrome and intellectual disability research
article

Mild premorbid intellectual impairment as a resilience factor in Down syndrome associated Alzheimer's disease

James Tyler Kennedy
article en

Abstract

Cognitive decline timing and slope differ depending on PII level, but AD biomarker pathology does not. If cognition is used for staging or endpoints in clinical trials, then PII should be considered.

Alzheimer s & DementiaVol. 21(S2)
Washington University in St. Louis (US)
Openalex Percentile: Top 27%
Down syndrome and intellectual disability research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Mild premorbid intellectual impairment as a resilience factor in Down syndrome associated Alzheimer's disease — James Tyler Kennedy · Alzheimer s & Dementia (2025) | TGRS Research Map | TGRS